Shares of Omega Protein Corp. (NYSE:OME) fell 1.1% on Tuesday . The stock traded as low as $20.64 and last traded at $20.82, with a volume of 89,500 shares trading hands. The stock had previously closed at $21.06.

Several brokerages recently weighed in on OME. Wunderlich initiated coverage on Omega Protein Corp. in a report on Thursday, April 28th. They issued a “buy” rating and a $22.00 price objective for the company. Zacks Investment Research lowered Omega Protein Corp. from a “buy” rating to a “hold” rating in a report on Thursday, July 7th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Omega Protein Corp. currently has an average rating of “Hold” and a consensus target price of $21.88.

The company’s 50-day moving average is $19.60 and its 200-day moving average is $19.69. The company has a market capitalization of $463.06 million and a P/E ratio of 15.34.

Omega Protein Corp. (NYSE:OME) last released its quarterly earnings results on Wednesday, May 4th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.36 by $0.04. The firm had revenue of $84.84 million for the quarter, compared to the consensus estimate of $84.74 million. During the same quarter last year, the company earned $0.12 earnings per share. The firm’s revenue was up 18.5% on a year-over-year basis. On average, equities research analysts predict that Omega Protein Corp. will post $1.71 EPS for the current fiscal year.

A number of large investors have recently added to or reduced their stakes in OME. Engineers Gate Manager LP purchased a new stake in Omega Protein Corp. during the fourth quarter worth about $1,173,000. American Century Companies Inc. purchased a new stake in Omega Protein Corp. during the fourth quarter worth about $1,847,000. California Public Employees Retirement System boosted its stake in Omega Protein Corp. by 26.3% in the fourth quarter. California Public Employees Retirement System now owns 119,000 shares of the company’s stock worth $2,642,000 after buying an additional 24,800 shares during the period. Morgan Stanley boosted its stake in Omega Protein Corp. by 185.2% in the fourth quarter. Morgan Stanley now owns 159,636 shares of the company’s stock worth $3,543,000 after buying an additional 103,671 shares during the period. Finally, Russell Frank Co boosted its stake in Omega Protein Corp. by 51.6% in the fourth quarter. Russell Frank Co now owns 370,981 shares of the company’s stock worth $8,524,000 after buying an additional 126,238 shares during the period.

Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products across the world. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists primarily of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.